Details for Patent: 10,016,407
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 10,016,407 protect, and when does it expire?
Patent 10,016,407 protects GOPRELTO and is included in one NDA.
Summary for Patent: 10,016,407
| Title: | Pharmaceutical compositions and methods of using the same |
| Abstract: | Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described. |
| Inventor(s): | Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA) |
| Assignee: | GENUS LIFESCIENCES INC. (Allentown, PA) |
| Application Number: | 15/849,575 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,016,407 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,016,407
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | GOPRELTO | cocaine hydrochloride | SOLUTION;NASAL | 209963-001 | Dec 14, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | METHOD OF ADMINISTERING A LOCAL ANESTHETIC PRIOR TO PERFORMING A DIAGNOSTIC OR SURGICAL PROCEDURE ON A SUBJECT WITH HEPATIC OR RENAL IMPAIRMENT | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
